The trouble with translational medicine

Area of Science:

• Biomedical Research
• Translational Science
• Drug Development

Background:

• Effective translation of biomedical research into therapeutics is hindered by extrinsic factors and a lack of systematic prioritization.
• There is an overemphasis on bench-to-bedside research without adequately understanding human pathophysiology.
• Therapeutic concepts often stem from experimental models that do not accurately reflect human genetics, leading to non-applicable drug development.

Purpose of the Study:

• To identify key challenges in biomedical research translation.
• To propose a more systematic approach to drug development.
• To emphasize the need for improved understanding of human pathophysiology and informative clinical trials.

Main Methods:

• Literature review and analysis of common themes in translational research challenges.
• Critical evaluation of current drug development paradigms.
• Discussion of the limitations of surrogate biomarkers and feedback loops in clinical trials.

Main Results:

• Biomedical research translation is hampered by a disproportionate focus on experimental models over human pathophysiology.
• Current clinical trial designs often lack mechanisms for obtaining informative feedback on efficacy and failure.
• The feedback loop from clinical trials is frequently delayed and uninformative, hindering iterative improvement.

Conclusions:

• Drug development must prioritize a deeper understanding of human pathophysiology.
• Clinical trials should be designed to provide mechanistic insights, not just efficacy data.
• The biomedical research community needs to reform funding, publication, and reward systems to foster learning from failures and improve therapeutic translation.